University of Nebraska Diagnostic Laboratory

January 1996 through March 1998

Below are presented in vitro sensitivity data on bovine isolates obtained from cases of BRD at the University of Nebraska Veterinary Diagnostic Laboratory, Lincoln, from January 1996 through March 10, 1998.

Florfenicol continues to demonstrate outstanding activity against the three major bacteria associated with BRD. There is evidence of increasing resistance to other antibiotics commonly employed in the treatment of this disease.

Number Tested / Percent Sensitive

Mannheimia (Pasteurella) haemolytica

 199619971998
Florfenicol29/10078/10064/100
Spectinomycin32/62.577/57.165/60
Tetracycline32/78.178/66.865/56.9
Tilmicosin32/87.577/76.664/68.7

Pasteurella multocida

 199619971998
Florfenicol10/10043/10038/100
Spectinomycin13/10045/64.441/82.9
Tetracycline13/10045/8041/73.2
Tilmicosin13/92.345/88.941/92.2

Haemophilus somnus

 199619971998
Florfenicol12/10029/10017/100
Spectinomycin13/84.629/72.417/76.5
Tetracycline13/92.329/86.217/88.2
Tilmicosin13/69.228/57.116/62.5